Literature DB >> 6288754

Attenuated forms of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

P A Lee, Z Rosenwaks, M D Urban, C J Migeon, W D Bias.   

Abstract

A variety of mild forms of congenital adrenal hyperplasia (CAH) due to partial 21-hydroxylase deficiency have recently been described. We report two families in whom members presented with CAH with various degrees of enzyme deficiency. In family A, two children had the classical salt-losing CAH. Their male sibling and mother presented a very mild asymptomatic form of CAH, characterized by elevated basal plasma levels of 17-hydroxyprogesterone (17-OHP) and exaggerated responses of progesterone and 17-OHP to ACTH stimulation. The Hormonal profile and HLA types of these two individuals suggested allelic compounds, having one mutant gene for classical CAH and another for a mild form. In family B, the proband presented an attenuated form of CAH, manifested by amenorrhea and hirsutism, elevated basal levels of plasma 17-OHP and androgens, as well as markedly increased ACTH response. Two of her four siblings had the same ad HLA type, elevated basal plasma 17-OHP levels, and increased ACTH response. Their father, their paternal aunt, and their paternal uncle had the ab HLA type and normal basal plasma 17-OHP but markedly increased ACTH response. The haplotypes a, b, and d were considered to be linked to a mutation resulting in mild 21-hydroxylase deficiency, the homozygotes with ab HLA type having a milder form of CAH than the homozygotes with the ad HLA type. The wide spectrum of clinical and hormonal characteristics among homozygotes for the 21-hydroxylase deficiency trait suggests that their is a continuum of degree of enzyme deficiency. Furthermore, it suggests that most nonclassical subjects are allelic compounds for variable degrees of severity in the mutation at the 21-hydroxylase locus. More specifically, the study of families A and B shows that the so-called cryptic and attenuated forms of CAH have the same pathophysiological basis.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6288754     DOI: 10.1210/jcem-55-5-866

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  8 in total

1.  Late-onset congenital adrenal hyperplasia in a group of hyperandrogenic women.

Authors:  D K Hassíakos; J P Toner; G S Jones; H W Jones
Journal:  Arch Gynecol Obstet       Date:  1991       Impact factor: 2.344

2.  Phenotypic profiling of parents with cryptic nonclassic congenital adrenal hyperplasia: findings in 145 unrelated families.

Authors:  Radha Nandagopal; Ninet Sinaii; Nilo A Avila; Carol Van Ryzin; Wuyan Chen; Gabriela P Finkielstain; Sneha P Mehta; Nazli B McDonnell; Deborah P Merke
Journal:  Eur J Endocrinol       Date:  2011-03-28       Impact factor: 6.664

3.  Compensatory maturational deceleration of growth or "catch-down growth" in patients with congenital adrenal hyperplasia after delayed initiation of therapy.

Authors:  U Hunziker; R Largo; M Zachmann; A Prader
Journal:  Eur J Pediatr       Date:  1986-04       Impact factor: 3.183

4.  HLA and hormonal studies in 5 patients with late-onset 21-hydroxylase deficiency syndrome (21OHDS).

Authors:  C Scaroni; E Orlandini; C Venturi Pasini; M Gangemi; F Mantero
Journal:  J Endocrinol Invest       Date:  1986-02       Impact factor: 4.256

5.  Value of buserelin testing in the evaluation of hirsute women.

Authors:  B Ambrosi; T Re; E Passini; D Bochicchio; R Ferrario
Journal:  J Endocrinol Invest       Date:  1996-04       Impact factor: 4.256

6.  Detection of late onset steroid 21-hydroxylase deficiency by capillary gas chromatographic profiling of urinary steroids in children and adolescents.

Authors:  J Homoki; J Solyom; W M Teller
Journal:  Eur J Pediatr       Date:  1988-04       Impact factor: 3.183

7.  The endocrine pattern of late onset adrenal hyperplasia (21-hydroxylase deficiency).

Authors:  E Carmina; A M Gagliano; F Rosato; M Maggiore; A Jannì
Journal:  J Endocrinol Invest       Date:  1984-04       Impact factor: 4.256

8.  Adrenal insufficiency in a man with non-classical 21-hydroxylase deficiency: consequence or coincidence?

Authors:  A R Glass; S G Jackson; R S Perlstein; H L Wray
Journal:  J Endocrinol Invest       Date:  1994-09       Impact factor: 4.256

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.